Drug intelligence / Profile preview

CSAAC

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

CSAAC is a combination of antiseptic agents comprising chlorhexidine-based soap, 70% ethyl alcohol, and alcoholic chlorhexidine. It is utilized for skin preparation in surgical orthopedic procedures with the aim of preventing surgical site infections. Clinical trials have investigated its effectiveness in comparison to other antisepsis techniques.

Other names: Chlorhexidine-based Soap + 70% Ethyl Alcohol + Alcoholic Chlorhexidine

Beyond the preview

Go deeper on CSAAC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSAAC.

Explore the full profile